Alto Neuroscience (ANRO) Current Assets (2023 - 2026)

Alto Neuroscience has reported Current Assets for 4 years, with the latest figure at $269.1 million in Q1 2026.

• Quarterly Current Assets rose 64.58% year-over-year to $269.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $269.1 million (up 64.58% YoY) and the FY2025 annual result came in at $177.7 million, up 4.95% from the prior year.
• Current Assets improved to $269.1 million in Q1 2026 per ANRO's latest filing, from $177.7 million in the prior quarter.
• Over five years, Current Assets peaked at $269.1 million in Q1 2026 and troughed at $85.4 million in Q4 2023.
• A 4-year average of $174.2 million and a median of $173.5 million in 2024 frame the typical range for Current Assets.
• The sharpest annual moves came in 2024 and 2025: Current Assets jumped 98.31% in 2024, then decreased 24.02% in 2025.
• Over 4 years, Current Assets stood at $85.4 million in 2023, then surged by 98.31% to $169.3 million in 2024, then increased by 4.95% to $177.7 million in 2025, then jumped by 51.43% to $269.1 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $269.1 million, $177.7 million, and $139.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.